Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know
Oncology and Therapy · 2024-09 · 12 (3) · 375-394
DOI: 10.1007/s40487-024-00283-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology and Therapy, online erschienen am 15.06.2024. Verfasst von Yang Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University Peopl…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In human leukocyte antigen (HLA)-mismatched allogeneic stem cell transplantation settings, donor-specific anti-HLA antibodies (DSAs) can independently lead to graft failure, including both primary graft rejection and primary poor graft function. Although several strategies, such as plasma exchange, intravenous immunoglobulin, rituximab, and bortezomib, have been used for DSA desensitization, the effectiveness of desensitization and transplantation outcomes in some patients remain unsatisfactory. In this review, we summarized recent research on the prevalence of anti-HLA antibodies and the underlying mechanism of DSAs in the pathogenesis of graft failure. We mainly focused on desensitization strategies for DSAs, especially novel methods that are being investigated in the preclinical stage and those with promising outcomes after preliminary clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital &, Peking University Institute of Hematology, No. 11 Sout…
- Department of Experimental Medicine, School of Public Health, Xiamen University, Xiamen, People's Republic of China.
Zitieren
APA
Zhou, Y., Chen, Y. L., Huang, X. Y., & Chang, Y. J. (2024). Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know. Oncology and Therapy, 12(3), 375-394. https://doi.org/10.1007/s40487-024-00283-6
Vancouver
Zhou Y, Chen YL, Huang XY, Chang YJ. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know. Oncology and Therapy. 2024;12(3):375-394. doi:10.1007/s40487-024-00283-6
BibTeX
@article{Zhou2024,
author = {Zhou, Yang and Chen, Yu-Lun and Huang, Xi-Yi and Chang, Ying-Jun},
title = {Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know},
journal = {Oncology and Therapy},
year = {2024},
volume = {12},
number = {3},
pages = {375--394},
doi = {10.1007/s40487-024-00283-6}
}
EUVIMED